Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | HLD-0915 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on HLD-0915, a putative AR-targeting therapy (Feb 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| HLD-0915 | HLD0915|HLD 0915 | Limited information is currently available on HLD-0915, a putative AR-targeting therapy (Feb 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06800313 | Phase Ib/II | HLD-0915 | A Study of HLD-0915 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) | Recruiting | USA | GBR | 0 |